Canoe EIT Income Fund Announces February 2025 Monthly Distribution and Quarterly Distribution on Preferred Units
CALGARY, Alberta, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Canoe EIT Income Fund (the 'Fund') (TSX - EIT.UN) announces the February 2025 monthly distribution of $0.10 per unit. Additionally, the Fund announces a quarterly distribution for preferred units. Cumulative Redeemable Series 1 (EIT.PR.A) and Series 2 Preferred (EIT.PR.B) unitholders will receive a distribution of $0.30 per unit. Unitholders of record on February 24, 2025, will receive distributions payable on March 14, 2025.
About Canoe EIT Income FundCanoe EIT Income Fund is one of Canada's largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN, and is actively managed by Robert Taylor, Senior Vice President and Chief Investment Officer, Canoe Financial.
About Canoe Financial Canoe Financial is one of Canada's fastest growing independent mutual fund companies managing over $19.5 billion in assets across a diversified range of award-winning investment solutions. Founded in 2008, Canoe Financial is an employee-owned investment management firm focused on building financial wealth for Canadians. Canoe Financial has a significant presence across Canada, including offices in Calgary, Toronto and Montreal.
For further information, please contact:Investor Relations1–877–434–2796www.canoefinancial.cominfo@canoefinancial.comThe Fund makes monthly distributions of an amount comprised in whole or in part of Return of Capital (ROC) of the net asset value per unit. A ROC reduces the amount of your original investment and may result in the return to you of the entire amount of your original investment. ROC that is not reinvested will reduce the net asset value of the fund, which could reduce the fund's ability to generate future income. You should not draw any conclusions about the fund's investment performance from the amount of this distribution.
Commissions, trailing commissions, management fees and expenses all may be associated with investment funds. Please read the information filed about the fund on www.sedar.com before investing. Investment funds are not guaranteed and past performance may not be repeated.
This communication is not to be construed as a public offering to sell, or a solicitation of an offer to buy securities. Such an offer can only be made by way of a prospectus or other applicable offering document and should be read carefully before making any investment. This release is for information purposes only. Investors should consult their Investment Advisor for details and risk factors regarding specific strategies and various investment products.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
ThinkCareBelieve: Week 21 of America's Progress under President Trump
Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: has published an article on the 21st week of America under the leadership of President Donald J. Trump. America is making strong progress toward prosperity and ThankCareBelieve's article shows this weeks numbers and indicators supporting that. Prices are going down. Tariffs are working. Inflation is gone. The economy is strong and once the One Big Beautiful Bill is passed, the economy will be booming. The article has a report by Maria Bartiromo that the CPI (Consumer Price Index) is out and the numbers are better than expected, surprising everyone. The trade deal with China is now complete, allowing China's markets to open up for American products which will help American business soar. The article shows this week's Los Angeles riots have sparked several investigations where they actually were paid anarchy by those wanting to disrupt American 21st week ends on Flag Day, the 25th Anniversary of the U.S. Army and the Birthday of President Donald J. Trump. The article shows how strong America has become with record number of enlistments and re-enlistments, President Trump attended an Invest in America Event and the President signing an end to costly and impractial EV Mandates. The Halt Fentanyl Act has been passed and is ready to be signed. The article also covers Secretary Kennedy's huge steps to restore public trust by appointing a new board to the Advisory Committee for Immunization Practices (ACIP), including the appointment of Dr. Robert Malone, M.D. is an outlook. ThinkCareBelieve's mission for Peace advocacy facilitates positive outcomes and expanded possibilities. To achieve Peace, we will find the commonalities between diverse groups and bring the focus on common needs, working together toward shared goals. Activism is an important aspect of ThinkCareBelieve, because public participation and awareness to issues needing exposure to light leads to justice. Improved transparency in government can lead to changes in policy and procedure resulting in more fluid communication between the public and the government that serves them. America needs hope right now, and Americans need to be more involved in their government. ### CONTACT: CONTACT: Joanne COMPANY: ThinkCareBelieve EMAIL: joanne@ WEB: in to access your portfolio
Yahoo
an hour ago
- Yahoo
Nuclear Air Filtration for HVAC Managers: Why the Nuclear Comeback Demands Next-Gen Filtration Standards
The Big Reveal: What HVAC Managers Must Know About High-Performance Filtration. Camfil Nuclear air filters are used for containment control during dismantling or maintenance work at a nuclear sites. Nuclear Energy is Making a Comeback in the U.S. Why Advanced Air Filtration is More Vital Than Ever Riverdale, NJ, June 14, 2025 (GLOBE NEWSWIRE) -- Learn how Camfil supports safe nuclear energy expansion in the U.S. with cutting-edge containment solutions. With nuclear energy making a significant comeback in the United States as a reliable and carbon-free power source, advanced air filtration systems are playing a pivotal role in ensuring safety and operational integrity. Camfil, a global leader in clean air solutions, emphasizes the essential role of containment and air filtration technology in supporting the safe expansion of nuclear power with an extensive new guide. The U.S. government's goal to triple nuclear energy capacity by 2050 and the 20% increase in planned nuclear reactor projects reported in 2023 signal a pivotal shift towards sustainable energy solutions. Large technology companies such as Amazon, Google, and Meta are also investing in nuclear power to meet their ambitious clean energy goals, highlighting its importance as part of the renewable energy ecosystem. However, the expansion of nuclear energy production demands a renewed focus on maintaining safety standards. Modern nuclear facilities must integrate robust safety measures to mitigate airborne hazards and prevent the release of radioactive contaminants. Advanced filtration systems are essential for managing these risks, ensuring that nuclear energy remains a viable and sustainable solution for addressing the challenges of global energy demand. "Containment of airborne contaminants and air filtration play a critical role in ensuring the safety and operational integrity of nuclear power plants," said Paul Charbonneau, Nuclear Air Filtration Systems Segment Manager at Camfil, "As the nuclear industry experiences a renaissance, advanced containment and filtration systems serve as a key enabler, reinforcing the viability of nuclear energy as a sustainable and secure power source. Camfil remains dedicated to driving innovation in containment and air filtration technology, continuously developing solutions that meet the highest safety and performance standards." The guide details Camfil's proven track record in pioneering nuclear air filtration, dating back to 1963. The company's innovative containment solutions, such as the CamContain series, are specifically engineered for high-risk environments such as nuclear facilities. Featuring HEPA filters designed to capture 99.97% of particles as small as 0.3 microns, gas-tight stainless-steel construction, and advanced mechanisms such as bag-in/bag-out (BIBO) systems for safe filter replacement, these cutting-edge solutions ensure optimal safety and efficiency. Regulatory bodies, including the U.S. Nuclear Regulatory Commission (NRC), continue to mandate stringent standards for air filtration and containment systems to protect workers, local communities, and the environment. Camfil's technologies are designed to meet and exceed these requirements, providing nuclear facilities with reliable, state-of-the-art solutions for airborne hazard management. As the U.S. harnesses the potential of nuclear power to achieve both energy security and sustainability goals, Camfil's air filtration solutions remain at the forefront of maintaining safety and reinforcing public confidence in this vital energy source. Learn more by accessing the full guide: About Camfil Camfil Nuclear Air Filtration & HVAC The Camfil Group is headquartered in Stockholm, Sweden, and has 29 manufacturing sites, six R&D centers, local sales offices in 35+ countries, and 5,700 employees and growing. We proudly serve and support customers in a wide variety of industries and communities across the world. To discover how Camfil USA can help you to protect people, processes, and the environment, visit us at Contact Information Lynne Laake Camfil USA Air Filters Phone: 888-599-6620 Email: Attachment Nuclear Energy is Making a Comeback in the U.S. Why Advanced Air Filtration is More Vital Than Ever
Business Upturn
2 hours ago
- Business Upturn
IOVA SHAREHOLDERS: Iovance Biotherapeutics, Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by July 14 Deadline (NASDAQ:IOVA)
NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
